MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)

A study to evaluate the cardiac and metabolic effects of MK0767 in patients with Type 2 Diabetes.

This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Inclusion Criteria:

• You are taking at least one medication for high blood sugar
• Age 21 to 80

Exclusion Criteria:

• History of Type 1 Diabetes Mellitus
• Currently on estrogen replacement therapy regimen
• Currently on a weight loss program with ongoing weight loss or taking medications for weight loss
• Having surgery 30 days before starting the study
• Have taken any other investigational drug in the past 90 days
• Have Hepatitis B or C
• Active liver or gallbladder disease